 |
 |
 |
|
Bictegravir/FTC/TAF CSF Diffusion
in HIV-Infected Patients with CNS Impairment
|
|
|
CROI 2020
Reported by Jules Levin
Antoine Cheret1,2, Thibaut Gele1,3, Alicia Castro Gordon1, Valerie Furlan1, Coralie Pallier1, Pierre-Hadrien Becker1,
PilartxoCatalan1, Cecile Goujard1,4,5, Anne-Marie Taburet1,3, Jacques Gasnault1,3, Helène Gouget3, Aurelie Barrail-Tran1,3,6
1AP-HP. Universite Paris Saclay, France∼ 2Universite Paris-Descartes, Sorbonne Paris Cite, France∼ 3Universite Paris-Saclay, Inserm, CEA, Centre de recherche en Immunologie des infections virales et des maladies
1AP-HP. Universite Paris Saclay, France∼ 2Universite Paris-Descartes, Sorbonne Paris Cite, France∼ 3Universite Paris-Saclay, Inserm, CEA, Centre de recherche en Immunologie des infections virales et des maladies autoimmunes, France∼ 4Universite Paris-Saclay, UVSQ, Inserm, CESP, France∼ 5Universite Paris-Saclay, Faculte de Medecine, France∼ 6Universite Paris-Saclay, Faculte de Pharmacie, France∼



|
|
|
 |
 |
|
|